Skip to main content

Table 2 Antibiotic susceptibility in patients with acute postoperative, Gram-negative endophthalmitis resistant to both ceftazidime and amikacin

From: Combined ceftazidime and amikacin resistance among Gram-negative isolates in acute-onset postoperative endophthalmitis: prevalence, antimicrobial susceptibilities, and visual acuity outcome

No.

Organism

A

Cefa

Cefta

Chlor

Genta

Cipro

Gati

Imip

Oflox

Pipera

Ticar

1

Pseudomonas aeruginosa

R

R

R

R

R

S

S

R

S

-

-

2

Pseudomonas aeruginosa

R

R

R

R

R

S

S

R

S

R

R

3

Enterobacter

R

R

R

R

R

R

R

S

R

R

R

4

Enterobacter

R

R

R

R

R

R

R

S

R

R

R

5

Pseudomonas aeruginosa

R

R

R

R

R

R

R

S

R

R

R

6

Haemophilus

R

-

R

S

R

S

S

R

S

-

-

7

Pseudomonas aeruginosa

R

-

R

R

R

R

R

R

R

R

R

8

Enterobacter

R

-

R

R

R

R

R

S

R

R

R

9

Pseudomonas aeruginosa

R

-

R

R

R

S

S

R

S

-

-

10

Pseudomonas aeruginosa

R

-

R

R

R

R

R

S

R

R

R

11

Pseudomonas aeruginosa

R

R

R

R

R

S

S

R

S

-

-

12

Pseudomonas aeruginosa

R

R

R

R

R

R

R

S

R

R

R

  1. A, amikacin; Cefa, cefazolin; Cefta, ceftazidime; Chlor, chloramphenicol; Genta, gentamicin; Cipro, ciprofloxacin; Gati, gatifloxacin; Imip, imipenum; Oflox, ofloxacin; Pipera, piperacillin; Ticar, ticarcillin; S, sensitive; R, resistant.